Dagfinn Ogreid
Overview
Explore the profile of Dagfinn Ogreid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Helden J, Eidens M, Fuhrlander J, Weiskirchen R, Ogreid D
J Gastrointest Oncol
. 2024 Sep;
15(4):1957-1961.
PMID: 39279969
Background: Colorectal cancer (CRC) is the third most common form of cancer worldwide in terms of incidence and the second in terms of mortality with 1.9 million new cases and...
2.
Franck S, Eidens M, Fuhrlander J, Ogreid D
Clin Lab
. 2024 Jan;
70(1).
PMID: 38213210
Background: In this case study, the patient first had a colonoscopy based on an incidental episode of vomiting and abdominal pain. Materials And Methods: Two months after recovery, a multitarget...
3.
Sorbye H, Berglund A, Tveit K, Ogreid D, Wanderas E, Wentzel-Larsen T, et al.
Acta Oncol
. 2007 Oct;
46(7):982-8.
PMID: 17917829
Two consecutive studies have evaluated the efficacy of oxaliplatin combined with the Nordic bolus schedule of 5-fluorouracil and folinic acid as first-line treatment in metastatic non-resectable colorectal cancer. One hundred...
4.
Ogreid D, Hamre E
Eur J Gastroenterol Hepatol
. 2007 Jul;
19(8):725-7.
PMID: 17625445
We found, in an asymptomatic patient with familial occurrence of malignancy, that mutations in the oncogene Kras could be detected in stool 18 months before a premalignant polyp was detected...
5.
Sorbye H, Glimelius B, Berglund A, Fokstuen T, Tveit K, Braendengen M, et al.
J Clin Oncol
. 2004 Jan;
22(1):31-8.
PMID: 14701765
Purpose: This Nordic multicenter phase II study evaluated the efficacy and safety of oxaliplatin combined with the Nordic bolus schedule of fluorouracil (FU) and folinic acid (FA) as first-line treatment...